| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/17/2007 | US7205386 Truncated CD200 |
| 04/17/2007 | US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives |
| 04/17/2007 | US7205314 Compounds for the treatment of dementia related diseases |
| 04/17/2007 | US7205309 Obesity therapy; administering orlistat |
| 04/17/2007 | US7205306 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 04/17/2007 | US7205303 Substituted heterocyclic compounds |
| 04/17/2007 | US7205302 Anticoagulants; antilipemic agents; cardiovascular disorders |
| 04/17/2007 | US7205300 Aryl fused azapolycyclic compounds |
| 04/17/2007 | US7205290 Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use |
| 04/17/2007 | US7205275 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 04/17/2007 | US7205151 Antiinflammatory agents; skin disorders |
| 04/17/2007 | US7205139 Expression vector comprising nucleotide sequences coding serine protease for use in diagnosis and treatment of thrombotic disorders |
| 04/17/2007 | US7205126 Made by disrupting HPV-virus-like particles including a chelating agent, mixing them with plasmids and reassembling them into the pseudoviruses (VLPs with plasmids inside) adding a stop buffer to reassemble the VLPs into pseudoviruses; administering to the mucosa; can be applied in gene therapy |
| 04/17/2007 | CA2386799C Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists |
| 04/17/2007 | CA2374635C Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester |
| 04/17/2007 | CA2371645C Naphtalene or heterocyclically substituted benzimidazoles as parp inhibitors |
| 04/17/2007 | CA2341690C Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 04/17/2007 | CA2318381C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 04/17/2007 | CA2250586C Meta-substituted phenylene sulphonamide derivatives |
| 04/17/2007 | CA2123912C Muramyl compounds for treatment of septic shock |
| 04/12/2007 | WO2007041712A1 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/12/2007 | WO2007041076A2 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | WO2007040636A1 Methods for reducing blood pressure |
| 04/12/2007 | WO2007040208A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/12/2007 | WO2007040128A1 Therapeutic agent for heart failure |
| 04/12/2007 | WO2007040006A1 Activator for peroxisome proliferator-activated receptor (pparϝ) and composition containing the activator for preventing or ameliorating specific symptom |
| 04/12/2007 | WO2007040005A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPARα) AND COMPOSITION CONTAINING THE ACTIVATOR FOR PREVENTING OR AMELIORATING SPECIFIC SYMPTOM |
| 04/12/2007 | WO2007039945A1 Lipid metabolism improving composition |
| 04/12/2007 | WO2007039470A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 04/12/2007 | WO2007039438A1 Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 04/12/2007 | WO2007039297A1 Imidazopyridine derivatives as a2b adenosine receptor antagonists |
| 04/12/2007 | WO2007039285A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 04/12/2007 | WO2007039134A1 Combination therapy comprising substituted oxazolidinones for the prevention and treatment of cerebral circulatory disorders |
| 04/12/2007 | WO2007038943A1 Y2 selective receptor agonists for therapeutic interventions |
| 04/12/2007 | WO2007038874A1 Grape seed extract and its constituents for use as cyp2a6 inhibitors |
| 04/12/2007 | WO2007038865A1 Substituted quinolines as inhibitors of leukotriene biosynthesis |
| 04/12/2007 | WO2007022101A3 Treatment of diseases by subcutaneous administration of a vegf antagonist |
| 04/12/2007 | WO2007017538A3 Method of obtaining amlodipine besylate |
| 04/12/2007 | WO2007015002A3 Novel crystalline iv form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form |
| 04/12/2007 | WO2007008937A8 Adiponectin variants |
| 04/12/2007 | WO2006136580A3 2-(phenylamino)benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 04/12/2007 | US20070082957 2-chloro-5-(3-oxopropyl)-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide; P2X7 receptor antagonists; inflammatory, immune or cardiovascular diseases |
| 04/12/2007 | US20070082921 Quinazoline derivatives as antitumor agents |
| 04/12/2007 | US20070082910 Specific nad(p)h oxidase inhibitor |
| 04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
| 04/12/2007 | US20070082888 Containing a piperidine ring, e.g., N-(p-(1-(alpha(propyl-aminocarbonyl)benzyl)piperidin-4-yl)phen yl)-o-(p-CF3-phenyl)- benzamide, for therapy of hyperlipidemia, obesity and type II diabetes |
| 04/12/2007 | US20070082341 Human phospholipases |
| 04/12/2007 | US20070081970 G-csf-containing substance for fibroblast recruitment and g-csf-contianing therapeutic agent for wound healing |
| 04/12/2007 | DE112005000737T5 Mit Heparansulfat-Zuckerketten modifizierte Heparin-bindende Proteine, Verfahren zur Erzeugung derselben und Arzneimittel, welche dieselben enthalten With heparan sulfate sugar chains modified heparin-binding proteins, methods for producing the same and pharmaceutical compositions containing the same |
| 04/12/2007 | CA2624882A1 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/12/2007 | CA2624879A1 Imidazopyridine derivatives as a2b adenosine receptor antagonists |
| 04/12/2007 | CA2624468A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 04/12/2007 | CA2624357A1 Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | CA2624354A1 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | CA2624345A1 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/12/2007 | CA2624323A1 Combination therapy comprising substituted oxazolidinones for the prevention and treatment of cerebral circulatory disorders |
| 04/12/2007 | CA2624294A1 Substituted quinolines as inhibitors of leukotriene biosynthesis |
| 04/12/2007 | CA2624131A1 Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia |
| 04/12/2007 | CA2623813A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/12/2007 | CA2623715A1 Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 04/12/2007 | CA2623693A1 Methods for reducing blood pressure |
| 04/12/2007 | CA2623094A1 Y2 selective receptor agonists for therapeutic interventions |
| 04/12/2007 | CA2621326A1 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 04/12/2007 | CA2621040A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 04/11/2007 | EP1772464A2 Methods of identifying indirect agonists of IGF-1 |
| 04/11/2007 | EP1772153A2 Method for the prevention of tissue elastic fiber injury |
| 04/11/2007 | EP1772150A1 Benzothiophene formulations of a specific dosage |
| 04/11/2007 | EP1772149A1 Drug for prevention or treatment of diabetes |
| 04/11/2007 | EP1772147A2 Method for increasing the oral bioavailability of S-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]-2-methylpropanethioate |
| 04/11/2007 | EP1772143A1 Peroxisome proliferator-activated receptor (ppar) activator and drugs, supplements, functional foods and food additives using the same |
| 04/11/2007 | EP1771455A2 Oxidative degradation products of atorvastatin calcium |
| 04/11/2007 | EP1771425A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 04/11/2007 | EP1771194A2 Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface |
| 04/11/2007 | EP1771178A1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 04/11/2007 | EP1511759A4 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 04/11/2007 | EP1501838B1 A process for the preparation of clopidogrel |
| 04/11/2007 | EP1490093A4 Methods and compositions for the treatment of ischemia |
| 04/11/2007 | EP1480972B1 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
| 04/11/2007 | EP1471930B1 Use of erythropoietin for the preventive or curative treatment of cardiac failure |
| 04/11/2007 | EP1392641B1 Substituted cyclohexane-1,4-diamine derivatives |
| 04/11/2007 | EP1351938B1 Phenyl derivatives |
| 04/11/2007 | EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 04/11/2007 | EP1272177B1 Method and formulation for treating resistance to antihypertensives and related conditions |
| 04/11/2007 | EP1239884B1 Methods for preparing pharmaceutical formulations |
| 04/11/2007 | EP1207868B1 Pharmaceutical tramadol salts |
| 04/11/2007 | EP1123094B1 Therapeutic compositions (ii) |
| 04/11/2007 | EP1015439B1 Prenyl transferase inhibitors |
| 04/11/2007 | CN1946732A Adenosine receptor agonists |
| 04/11/2007 | CN1946726A Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 04/11/2007 | CN1946717A Benzimidazole derivative and its use |
| 04/11/2007 | CN1946699A Pyridazinone ureas as antagonists of alpha4 integrins |
| 04/11/2007 | CN1946426A Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof |
| 04/11/2007 | CN1946396A Medicine for prevention and/or treatment of ischemic circulatory disease |
| 04/11/2007 | CN1946395A 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors |
| 04/11/2007 | CN1946389A Methods and compositions for the treatment of myocardial conditions |
| 04/11/2007 | CN1944663A Method for preparing avenin ACE inhibiting peptide |
| 04/11/2007 | CN1944647A Dopamine receptor new sub-type D5B gene and coded protein and use |
| 04/11/2007 | CN1944448A Puerarin derivative and its medicinal use |
| 04/11/2007 | CN1944433A 3-ene-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid amino acid amide, its synthetic method and light power therapeutic medicine |
| 04/11/2007 | CN1944432A 3-(1-alkoxy ethyl)-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid, its synthetic method and light power therapeutic medicine |